...A. And when you look at diabetes, there's 2.6 times to 2.5 times the amount of expenses for those without. B. So when you think about that, there's about 25 million people or about 10% of the population, covering about 26% of our dollars. C. Over the course of 2024, we delivered $4.33 billion. D. It was organic growth of 12% over the course of the year. E. Interactive base grew 25%. F. So we were serving 2.8 million to 2.9 million customers globally. G. So we submitted our G7 15-day CGM system to the FDA for review. H. Malaysia is now up and running, making millions and millions of sensors, and we also broke ground in Ireland, which will be our third or, as I say, fourth manufacturing facility over time. I. And we also delivered 100 basis points of operating leverage. J. And over the course of the past six years, we've delivered about 2,500 basis points of operating expense expansion. K. And so our guidance was really is $4.6 billion. L. which represents 14% growth. M. At that adjusted...
